Orchid Pharma Limited, (‘Orchid Pharma’) based in Chennai, India, the only Indian pharmaceutical company to have ever invented a New Chemical Entity (NCE), today announced the launch of its new drug - Cefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract infections (cUTI), Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) indications.

总部位于印度钦奈的兰花制药有限公司（Orchid Pharma Limited，简称“兰花制药”）是印度唯一一家发明新化学实体（NCE）的制药公司，今天宣布推出其新药头孢吡肟-恩美唑巴坦，该药已被批准用于治疗复杂尿路感染（cUTI），医院获得性肺炎（HAP）和呼吸机相关性肺炎（VAP）适应症。

In a landmark collaboration, Orchid Pharma has partnered with Cipla Limited (‘Cipla’) to ensure widespread and rapid distribution of this breakthrough antibiotic combination across India.The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in the fight against AMR, a growing global health issue, reinforcing India’s leadership in medical innovation.

在一项具有里程碑意义的合作中，Orchid Pharma与Cipla Limited（“Cipla”）合作，以确保这种突破性的抗生素组合在印度广泛而快速地分布。头孢吡肟-恩美唑巴坦的推出标志着印度制药行业在对抗AMR（一个日益严重的全球健康问题）方面的一个重要里程碑，加强了印度在医疗创新方面的领导地位。

Orchid Pharma and Cipla are confident that this collaboration will set a new benchmark for addressing critical healthcare challenges through strategic partnerships and advanced research.The partnership between Orchid Pharma and Cipla combines Orchid's innovative drug development capabilities with Cipla's extensive distribution network and market presence.

兰花制药（Orchid Pharma）和Cipla相信，这一合作将为通过战略伙伴关系和先进研究应对重大医疗保健挑战树立新的基准。兰花制药和Cipla之间的合作关系将兰花的创新药物开发能力与Cipla广泛的分销网络和市场占有率相结合。

This collaboration aims to ensure that this life-saving medication reaches healthcare providers across India as quickly and efficiently as possible.Speaking on the launch, Mr. Manish Dhanuka, Managing Director Orchid Pharma said, 'With increasing resistance to the current drugs most commonly used for treatment of these indications – e.g.

这种合作旨在确保这种挽救生命的药物尽可能快速有效地到达印度各地的医疗保健提供者。兰花制药总经理曼尼什·达努卡在发布会上说，“随着对目前最常用于治疗这些适应症的药物的耐药性增加，例如。

Piperacillin-Tazobactam for cUTI – doctors were forced to start using Carbapenems – a reserve drug meant to be used when most other drugs don't work. Now, Orchid's Cefepime- Enmetazobactam will allow doctors to spare Carbapenems, prolonging their effective life by restricting their use.'Mr. Uma.

用于cUTI的哌拉西林-他唑巴坦（Piperacillin-Tazobactam）-医生被迫开始使用碳青霉烯类药物，碳青霉烯类药物是一种储备药物，在大多数其他药物不起作用的情况下使用。现在，兰花的头孢吡肟-恩美唑巴坦（Cefepime-Enmetazobactam）将允许医生节省碳青霉烯类药物，通过限制其使用来延长其有效寿命乌马先生。